BLUEPRINT MEDICINES CORP financial statements, including revenue, expenses, profit, and loss

The total revenue of 2L9 for the last quarter is 89.08 M EUR, and it's 36.64% higher compared to the previous quarter. The net income of Q1 24 is 82.61 M EUR.